Table 2.
Model system | CuA | Heme a | BNC* | His413 | Asp51 | Glu242 | Tyr244 | Lys319 | Asp364 | No. of replica and simulation lengths, ns |
C2-I | RED | OX | PM | D (0) | D (−1) | P (0) | D (0) | P (+1) | P (0) | 2 × 200 |
C2-II | OX | RED | PM | D (0) | D (−1) | P (0) | D (0) | P (+1) | P (0) | 2 × 200 |
C2-III | OX | OX | PR | D (0) | D (−1) | P (0) | D (−1) | P (+1) | P (0) | 1 × 200 |
C2-IV | OX | RED | PM | P (+1) | D (−1) | P (0) | D (0) | P (+1) | P (0) | 1 × 200 |
C2-V | RED | OX | PM | P (+1) | D (−1) | P (0) | D (0) | P (+1) | P (0) | 1 × 100 |
C2-VI | RED | OX | PM | D (0) | P (0) | P (0) | D (0) | P (+1) | P (0) | 1 × 100 |
C2-VII (MV)† | OX | OX | RED | D (0) | D (−1) | P (0) | P (0) | P (+1) | P (0) | 2 × 200 |
C2-VIII (FR)‡ | RED | RED | RED | D (0) | D (−1) | P (0) | P (0) | P (+1) | P (0) | 2 × 200 |
Protonation state changes of key amino acid residues (D, deprotonated; P, protonated; net charge in parentheses) compared with C2-I/II/III simulations are highlighted in bold. Configurations of the BNC in different states are defined in the footnotes. MV, mixed valence; OX, oxidized; RED, reduced.
BNC had chemical structures of: PM, Fe[IV] = O2−....HO−-Cu[II] TyrO•; PR, Fe[IV] = O2−....HO−-Cu[II] TyrO−; RED, Fe[II]……..Cu[I] TyrOH.
BNC reduced with CuA/heme a oxidized.
BNC reduced with CuA/heme a reduced.